Michael Zinner, MD
Advertisement
Michael Zinner, MD, is the CEO and executive medical director of Miami Cancer Institute.
Articles by Michael Zinner, MD
Advertisement
Latest Updated Articles
Evaluating the Link Between COVID-19 and Cancer Progression in 2023January 22nd 2024
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Long-Term OMNIVORE Data Show Durable Treatment-Free Survival in RCC
2
De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival
3
Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma
4
Phase 3 ENHANCE Trial: Magrolimab Adds Toxicity, Not Benefit, in MDS
5